Almac
Encyclopedia
Almac is a contract research organization based in the United Kingdom. Headquartered in Craigavon
, Northern Ireland
, the company employs about 3,300 in the United Kingdom and United States. The company provides integrated drug development services, research, manufacturing, to over 600 clients. Core services include diagnostics, sciences, clinical services, clinical technologies and pharmaceutical services. It was founded in 1968 as Galen by the late Sir Allen McClay.
Almac is involved in joint efforts with a couple of companies. It formed a deal with Hewlett-Packard
(HP), investing in the company's test applications software, which will help shorten the time that a drug spends in clinical trials.
Craigavon
Craigavon is a settlement in north County Armagh, Northern Ireland. It was a planned settlement that was begun in 1965 and named after Northern Ireland's first Prime Minister — James Craig, 1st Viscount Craigavon. It was intended to be a linear city incorporating Lurgan and Portadown, but this plan...
, Northern Ireland
Northern Ireland
Northern Ireland is one of the four countries of the United Kingdom. Situated in the north-east of the island of Ireland, it shares a border with the Republic of Ireland to the south and west...
, the company employs about 3,300 in the United Kingdom and United States. The company provides integrated drug development services, research, manufacturing, to over 600 clients. Core services include diagnostics, sciences, clinical services, clinical technologies and pharmaceutical services. It was founded in 1968 as Galen by the late Sir Allen McClay.
Almac is involved in joint efforts with a couple of companies. It formed a deal with Hewlett-Packard
Hewlett-Packard
Hewlett-Packard Company or HP is an American multinational information technology corporation headquartered in Palo Alto, California, USA that provides products, technologies, softwares, solutions and services to consumers, small- and medium-sized businesses and large enterprises, including...
(HP), investing in the company's test applications software, which will help shorten the time that a drug spends in clinical trials.